Loading clinical trials...
Loading clinical trials...
An Observational Study Into the Usage and Efficacy of Crestor 5mg as a Start Dosage in Achieving the LDL-C Target Level in Both Statin-naive and Treated Primary and Secondary Prevention Patients With a High Risk of a Cardiovascular Event.
Conditions
Locations
215
Netherlands
Research Site
's-Hertogenbosch, Netherlands
Research Site
't Zand Nh, Netherlands
Research Site
Alblasserdam, Netherlands
Research Site
Alkmaar, Netherlands
Research Site
Almelo, Netherlands
Research Site
Almere Stad, Netherlands
Start Date
February 1, 2006
Completion Date
January 1, 2009
Last Updated
August 30, 2011
NCT07307989
NCT03856476
NCT02634151
NCT01890889
NCT00408382
NCT01354327
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions